Literature DB >> 19095166

The comparative effectiveness of heart disease prevention and treatment strategies.

Thomas E Kottke1, Dennis A Faith, Courtney O Jordan, Nicolaas P Pronk, Randal J Thomas, Simon Capewell.   

Abstract

BACKGROUND: Policymakers must be able to calculate the comparative effectiveness of interventions to control heart disease if they are to optimize the population impact of programmatic initiatives.
METHODS: A model was created to calculate the number of deaths that would be prevented or postponed if perfect care for heart disease prevention and treatment were achieved--that is, the elimination of risk factors and the prescription of all effective medications before and between acute events, and the delivery of all effective therapies to individuals suffering an acute heart disease event. The impact of perfect care was calculated for a hypothetic population aged 30-84 years with risk-factor levels, event rates, current patterns of behavior, levels of treatment, and mortality rates resembling those of the U.S. The analysis was performed in 2007 and 2008.
RESULTS: In this population, 44% of all deaths were due to heart disease. Perfect care before the first heart disease event would prevent or postpone 33% of all deaths. Perfect care between acute events would prevent or postpone 23% of all deaths. Perfect care during acute events would prevent or postpone 8% of all deaths.
CONCLUSIONS: This direct comparison of heart disease prevention and treatment strategies indicates that nearly 90% of the impact from perfect care for heart disease would accrue from interventions before and between acute events. The impact of risk-factor interventions before or between events is amplified by the fact that these interventions also reduce the risk of death from other chronic diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19095166     DOI: 10.1016/j.amepre.2008.09.010

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  27 in total

1.  Partnering care delivery and research to optimize health.

Authors:  Laura A Coleman; Thomas E Kottke; Brian Rank; Douglas J Reding; Mark Selna; George J Isham; Andrew F Nelson; Robert T Greenlee
Journal:  Clin Med Res       Date:  2008-12

Review 2.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 3.  Global availability of cardiac rehabilitation.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

4.  A Randomized Trial of External Practice Support to Improve Cardiovascular Risk Factors in Primary Care.

Authors:  Michael L Parchman; Melissa L Anderson; David A Dorr; Lyle J Fagnan; Ellen S O'Meara; Leah Tuzzio; Robert B Penfold; Andrea J Cook; Jeffrey Hummel; Cullen Conway; Raja Cholan; Laura-Mae Baldwin
Journal:  Ann Fam Med       Date:  2019-08-12       Impact factor: 5.166

5.  We Can Save a Million Hearts.

Authors:  Thomas E Kottke; Sarah Horst
Journal:  Perm J       Date:  2019-06-14

6.  Philanthropy and Beyond: Creating Shared Value to Promote Well-Being for Individuals in Their Communities.

Authors:  Thomas E Kottke; Nico Pronk; Andrew R Zinkel; George J Isham
Journal:  Perm J       Date:  2017

7.  Associations of Accelerometry-Assessed and Self-Reported Physical Activity and Sedentary Behavior With All-Cause and Cardiovascular Mortality Among US Adults.

Authors:  Kelly R Evenson; Fang Wen; Amy H Herring
Journal:  Am J Epidemiol       Date:  2016-10-19       Impact factor: 4.897

8.  Computer methods for follow-up study of hemodynamic and disease progression in the stented coronary artery by fusing IVUS and X-ray angiography.

Authors:  Arso M Vukicevic; Nemanja M Stepanovic; Gordana R Jovicic; Svetlana R Apostolovic; Nenad D Filipovic
Journal:  Med Biol Eng Comput       Date:  2014-04-27       Impact factor: 2.602

9.  Cardiac rehabilitation series: Canada.

Authors:  Sherry L Grace; Stephanie Bennett; Chris I Ardern; Alexander M Clark
Journal:  Prog Cardiovasc Dis       Date:  2013-10-11       Impact factor: 8.194

10.  Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles.

Authors:  Pascal Bovet; Sarah Romain; Conrad Shamlaye; Shanti Mendis; Roger Darioli; Walter Riesen; Luc Tappy; Fred Paccaud
Journal:  Cardiovasc Diabetol       Date:  2009-06-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.